A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Owen A. O'Connor Cody Chiuzan Jennifer K Lue Jennifer E Amengual Enrica Marchi Lorenzo Falchi |
| Publication date | November 15, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |